Skip to main content
HCONRES 342 110th Congress House Health Drug approvals Estrogen Physicians Women Women's health

Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Introduced: May 6, 2008 See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 110th Congress
It was not agreed to before the 110th Congress (2007–2008) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
May 7, 2008
Referred to the Subcommittee on Health.
May 6, 2008
Referred to the House Committee on Energy and Commerce.
May 6, 2008
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.

What's happening now May 7, 2008

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • SCONRES 88 Related bill A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restr…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 8
All 8 Democratic 4 Republican 4
D
Courtney, Joe
Connecticut · Nov 19, 2008
 D
Sánchez, Linda T.
California · Jul 10, 2008
 R
Wittman, Robert J.
Virginia · Jul 10, 2008
 D
Lofgren, Zoe
California · Jun 11, 2008
 R
McCaul, Michael T.
Texas · Jun 5, 2008
 R
Boozman, John
Arkansas · Jun 4, 2008
 D
Baldwin, Tammy
Wisconsin · May 6, 2008
 R
Carter, John R.
Texas · May 6, 2008
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 342: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.. 110th Congress. Open America. https://openamerica.io/bill/110-HCONRES-342/
MLA
"H. Con. Res. 342: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HCONRES-342/.
Bluebook (legal)
H. Con. Res. 342, 110th Cong. (2026), https://openamerica.io/bill/110-HCONRES-342/.
Markdown link
[H. Con. Res. 342: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.](https://openamerica.io/bill/110-HCONRES-342/)
Report a problem